Liteng Shen

Hangzhou, 310058, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 18 publications

Discovery of a New and Selective HPK1 PROTAC for Enhancing Tumor Immunotherapy through Eliminating GLK Degradation.

Discovery of a New and Selective HPK1 PROTAC for Enhancing Tumor Immunotherapy through Eliminating GLK Degradation.

Journal: Journal of medicinal chemistry

Published: May 16, 2025

SARS-CoV-2 NSP14 inhibitor exhibits potent antiviral activity and reverses NSP14-driven host modulation.

SARS-CoV-2 NSP14 inhibitor exhibits potent antiviral activity and reverses NSP14-driven host modulation.

Journal: Nature communications

Published: April 12, 2025

PPI-CoAttNet: A Web Server for Protein-Protein Interaction Tasks Using a Coattention Model.

PPI-CoAttNet: A Web Server for Protein-Protein Interaction Tasks Using a Coattention Model.

Journal: Journal of chemical information and modeling

Published: January 06, 2025

KnoMol: A Knowledge-Enhanced Graph Transformer for Molecular Property Prediction.

KnoMol: A Knowledge-Enhanced Graph Transformer for Molecular Property Prediction.

Journal: Journal of chemical information and modeling

Published: September 26, 2024

Exploration of novel 20S proteasome activators featuring anthraquinone structures and their application in hypoxic cardiomyocyte protection.

Exploration of novel 20S proteasome activators featuring anthraquinone structures and their application in hypoxic cardiomyocyte protection.

Journal: Bioorganic & medicinal chemistry

Published: July 13, 2024

Discovery of New Phenyltetrazolium Derivatives as Ferroptosis Inhibitors for Treating Ischemic Stroke: An Example Development from Free Radical Scavengers.

Discovery of New Phenyltetrazolium Derivatives as Ferroptosis Inhibitors for Treating Ischemic Stroke: An Example Development from Free Radical Scavengers.

Journal: Journal of medicinal chemistry

Published: July 12, 2024

Discovery of a Highly Potent and Selective BRD9 PROTAC Degrader Based on E3 Binder Investigation for the Treatment of Hematological Tumors.

Discovery of a Highly Potent and Selective BRD9 PROTAC Degrader Based on E3 Binder Investigation for the Treatment of Hematological Tumors.

Journal: Journal of medicinal chemistry

Published: June 24, 2024

Virtual Screening and Molecular Docking: Discovering Novel METTL3 Inhibitors.

Virtual Screening and Molecular Docking: Discovering Novel METTL3 Inhibitors.

Journal: ACS medicinal chemistry letters

Published: May 08, 2024

Saikosaponin b1 Attenuates Liver Fibrosis by Blocking STAT3/Gli1 Interaction and Inducing Gli1 Degradation.

Saikosaponin b1 Attenuates Liver Fibrosis by Blocking STAT3/Gli1 Interaction and Inducing Gli1 Degradation.

Journal: Exploration (Beijing, China)

Published: April 07, 2024

Discovery of potential WEE1 inhibitors via hybrid virtual screening.

Discovery of potential WEE1 inhibitors via hybrid virtual screening.

Journal: Frontiers in pharmacology

Published: September 21, 2023

Identification of Potential JNK3 Inhibitors: A Combined Approach Using Molecular Docking and Deep Learning-Based Virtual Screening.

Identification of Potential JNK3 Inhibitors: A Combined Approach Using Molecular Docking and Deep Learning-Based Virtual Screening.

Journal: Pharmaceuticals (Basel, Switzerland)

Published: September 18, 2023

Identification and assessment of new PIM2 inhibitors for treating hematologic cancers: A combined approach of energy-based virtual screening and machine learning evaluation.

Identification and assessment of new PIM2 inhibitors for treating hematologic cancers: A combined approach of energy-based virtual screening and machine learning evaluation.

Journal: Archiv der Pharmazie

Published: September 18, 2023

Showing 1-12 of 18

Last Updated: 09/26/2026